With over 2,500 implants, the company’s EXTRA-AORTIC Ring is the first aortic annuloplasty device on the market to be specifically-designed and dedicated for the surgical repair of the aortic valve. This proven repair technique preserves the patient’s own native valve, thus avoiding replacement with an artificial, prosthetic heart valve.
CORONEO is driven by a passion to help cardiac patients. The company was founded with the vision to bring creative engineers together with internationally-renowned clinicians to develop clinically-superior medical devices that render surgery less-invasive for the patient, and cost-effective for the healthcare provider.
In the 20 years since its inception, the CORONEO brand has become synonymous with premium, high-end surgical instruments. The finest titanium alloys are used extensively to manufacture the most versatile instruments on the market that may be finely adjusted during use to the patient’s specific anatomy and to the surgeon’s preference in surgical set-up.
CORONEO is certified ISO 13485:2016. The company’s products have been granted regulatory approval (including CE Mark, FDA, and Health Canada), and are distributed throughout North America, Europe, and Asia via a network of dedicated distributors.